- Home
- ALPS vs MRCC Comparison
ALPS vs MRCC Comparison
Compare ALPS & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ALPS | MRCC |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.8M | 133.2M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | ALPS | MRCC |
|---|---|---|
| Price | $0.98 | $6.57 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 52.3K | ★ 135.4K |
| Earning Date | 07-24-2026 | 02-27-2026 |
| Dividend Yield | N/A | ★ 10.99% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,741,201.00 | ★ $43,742,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 40.25 | N/A |
| 52 Week Low | $0.56 | $5.86 |
| 52 Week High | $15.00 | $8.85 |
Technical Indicators
Market Signals| Indicator | ALPS | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 56.88 |
| Support Level | N/A | $6.08 |
| Resistance Level | N/A | $6.64 |
| Average True Range (ATR) | 0.00 | 0.20 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.00 | 93.85 |
Price Performance
Historical ComparisonAbout ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.